Eagle's Eye View: Your Weekly CV Update From ACC.org

Latest Episodes:

Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of August 8) Aug 10, 2022

Show notes

In this week’s View, Dr. Eagle discusses a scientific statement from the American Heart Association on the medical insights and clinical implications of sleep-disordered breathing and cardiac arrhythmias in adults, then looks at the prevalence and prognosis of discordant grading and flow-gradient patterns in patients with moderate aortic stenosis. Finally, Dr. Eagle explores JACC’s recently published paper on what clinicians need to know concerning the ongoing dobutamine shortage.

Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of August 1) Aug 03, 2022

Show notes

In this week’s View, Dr. Deepak Bhatt sits in for the vacationing Dr. Eagle to discuss the associations of atrial fibrillation after noncardiac surgery with stroke, subsequent arrhythmia, and death, then looks at how lipoprotein(a) is associated with the onset but not the progression of aortic valve calcification. Finally, Dr. Bhatt explores JACC’s State-of-the-Art Review of cardiovascular imaging for ischemic heart disease in women, and the need for a paradigm shift.

Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of July 25) Jul 27, 2022

Show notes

In this week’s View, Dr. Eagle discusses the JACC State of the Art Review of the definitions, outcomes, and evidence gaps surrounding aortic valve hemodynamics, then looks at cardiovascular outcomes in patients initiating first-line treatment of type 2 diabetes with sodium–glucose cotransporter-2 inhibitors versus metformin. Finally, Dr. Eagle explores the incidence, associated risk factors, and outcomes of postoperative arrhythmia after upper gastrointestinal surgery.

Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of July 18) Jul 20, 2022

Show notes

In this week’s View, Dr. Eagle discusses the association of blood viscosity with mortality among patients hospitalized with COVID-19, then looks at a systematic review and meta-analysis of beta-blockers and renin–angiotensin system inhibitors for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer. Finally, Dr. Eagle summarizes an open-label, blinded-outcome, randomized non-inferiority trial that examined thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke.

Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of July 11) Jul 13, 2022

Show notes

In this week’s View, Dr. Eagle discusses aneurysm growth, survival, and quality of life in untreated thoracic aortic aneurysms, then looks at the criteria for defining stages of cardiogenic shock severity and how that affects prognosis. Finally, Dr. Eagle explores the risk and timing of noncardiac surgery after transcatheter aortic valve implantation.

Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of July 4) Jul 06, 2022

Show notes

In this week’s View, Dr. Deepak Bhatt sits in for the vacationing Dr. Eagle to discuss the effects of early empagliflozin initiation on diuresis and kidney function in patients with acute decompensated heart failure (EMPAG-HF), then looks at the SynABPM 1 study that explores the association between hypotension during 2-hour ambulatory blood pressure monitoring and reflex syncope. Finally, Dr. Bhatt examines a report on the first commercial use in a multicenter experience of the PASCAL system, a transcatheter leaflet repair system for symptomatic tricuspid regurgitation.

Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of June 27) Jun 29, 2022

Show notes

In this week’s View, Dr. Eagle discusses the newly published table that lists drug-drug interactions with the anti-viral agent Paxlovid, used in treating COVID-19, then looks at an analysis of the LIFE Trial Run-In that examines the tolerability of sacubitril/valsartan in patients with advanced heart failure. Finally, Dr. Eagle explores the CABANA randomized clinical trial and its insights into the cost-effectiveness of catheter ablation versus antiarrhythmic drug therapy in atrial fibrillation.

Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of June 20) Jun 22, 2022

Show notes

In this week’s View, Dr. Eagle discusses rivaroxaban monotherapy vs combination therapy with antiplatelets on total thrombotic and bleeding events in atrial fibrillation with stable coronary artery disease, then looks at pre-operative atrial fibrillation and cardiovascular outcomes after non-cardiac surgery. Finally, Dr. Eagle explores a cohort study of claims databases that analyzes the risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA.

Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of June 13) Jun 15, 2022

Show notes

In this week’s View, Dr. Eagle discusses a prospective evaluation of cardiovascular risk ten years after a hypertensive disorder of pregnancy, then looks at the effect of varenicline added to counseling on smoking cessation among African American daily smokers. Finally, Dr. Eagle explores Dr. Nanette Wenger’s Call to Action for Cardiovascular Disease in Women: Epidemiology, Awareness, Access, and Delivery of Equitable Health Care in a Presidential Advisory from the American Heart Association.

Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of June 6) Jun 08, 2022

Show notes

In this week’s View, Dr. Eagle discusses the association of sugar-sweetened, artificially sweetened, and unsweetened coffee consumption with all-cause and cause-specific mortality, then looks at the association of sedentary time and physical activity with the risk of stroke among US adults. Finally, Dr. Eagle explores the prospective evaluation of autonomic dysfunction in post-acute sequela of COVID-19.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Eagle’s Eye View: Your Weekly CV Update From ACC.org

Related Podcasts

Links

Stay Connected